TheEdgeResearch
Home / Stocks / ELAN

Elanco Animal Health Incorporated (ELAN)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$22.92 ▲ +2.18%
Market Cap
$11.45B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.68
52-Wk Range
18.48-27.98
CEO
Jeffrey N. Simmons
Country
US
Currency
USD

Elanco Animal Health Incorporated operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Indianapolis, IN, US. The stock last traded at $22.92, up 2.18% on the session, giving a market capitalisation of $11.45B. On trailing twelve-month figures it carries a trailing P/E of -55.90, a net margin of -4.0%. Its beta of 1.68 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-55.90
Price / Sales
2.28
Price / Book
1.74
EV / EBITDA
19.17
Gross margin
52.6%
Operating margin
9.2%
Net margin
-4.0%
Return on equity
Debt / equity
0.59
Current ratio
2.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
9,650
IPO date
2018-09-20
Headquarters
Indianapolis, IN, US
About Elanco Animal Health Incorporated

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

Comparable companies

Elanco Animal Health Incorporated is most often compared with the following Healthcare names:

ALGNEHCENSGNBIXQGENRDYRVMDRVTYSOLVVTRS
More research on ELAN
ELAN technical analysis ELAN TheEdge Score Compare against peers
Open full interactive analysis & DCF →